Screening methods 2

• FC 21-01 • Suggesting ideal strategy of cervical cancer screening in Japan based on Fukui cervical cancer screening study See abstract > T. T. KUROKAWA • FC 21-02 • Emerging technologies in cervical cancer screening, the ETiCCS initiative See abstract > H. H. BUSSMANN • FC 21-03 • An electronic data system for an organized cervical cancer screening program in a rural setting in Ethiopia See abstract > F. F. JEDE • FC 21-04 • The impact of migration on cervical screening behaviour See abstract > H. H. PATEL • FC 21-05 • Evidence for clinical application of extended HPV genotyping in cervical cancer screening paradigms: a systematic review See abstract > J. J. ANDREWS • FC 21-06 • Higher rate of histologically confirmed CIN 2+ with increasing use of HPV, liquid base cytology and p16/Ki-67 in routine See abstract > A. A. XHAJA • FC 21-07 • The Study of Folate Receptor-Mediated Staining Solution (FRD™ ) Used for Cervical Cancer Screening See abstract > Y. Y. ZHAO • FC 21-08 • Cervical cancer screening participation in Belgium 2006-2012 See abstract > V. V. FABRI • FC 21-09 • Cervical cancer screening in Flanders See abstract > E. E. KELLEN • FC 21-10 • Cervical cancer screening in Iran: developing a new method See abstract > F. Farzaneh MOSHIRI